Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis
Haley Maria Dourron, Camilla K. Strauss, Peter S. Hendricks
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 984-1029
Open Access | Times Cited: 21

Showing 21 citing articles:

Restructuring insight: An integrative review of insight in problem-solving, meditation, psychotherapy, delusions and psychedelics
Kadi Tulver, Karl Kristjan Kaup, Ruben Laukkonen, et al.
Consciousness and Cognition (2023) Vol. 110, pp. 103494-103494
Open Access | Times Cited: 27
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs
Farah Zia, Michael H. Baumann, Sean J. Belouin, et al.
Neuropharmacology (2023) Vol. 233, pp. 109528-109528
Open Access | Times Cited: 20
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use
David S. Mathai, Daniel E. Roberts, Sandeep M. Nayak, et al.
Journal of Psychoactive Drugs (2025), pp. 1-12
Open Access
Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review
Viktoriia Kurkova, Olga Winkler, Andrew J. Greenshaw, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111333-111333
Closed Access
Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.
Gabrielle Agin-Liebes, Elizabeth M. Nielson, Michael A. Zingman, et al.
Psychology of Addictive Behaviors (2023) Vol. 38, Iss. 1, pp. 101-113
Closed Access | Times Cited: 15
Psilocybin in Palliative Care: An Update
Emily Whinkin, Moira Opalka, Conor Watters, et al.
Current Geriatrics Reports (2023) Vol. 12, Iss. 2, pp. 50-59
Open Access | Times Cited: 12
What Is in a Name? The Many Meanings of “Psychedelic”
Kelley C. O’Donnell, Daniel E. Roberts, Terence H. W. Ching, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 4, pp. 187-189
Closed Access | Times Cited: 10
Psychedelic Microdosing among Young Adults from Southern California
Alyssa F. Harlow, Peter S. Hendricks, Adam M. Leventhal, et al.
Journal of Psychoactive Drugs (2024), pp. 1-12
Closed Access | Times Cited: 3
5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?
Haley Maria Dourron, Charles D. Nichols, Otto Simonsson, et al.
Psychopharmacology (2023)
Closed Access | Times Cited: 8
Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychopathological Psychotic Experiences and Psychotic Disorders
Joseph La Torre, Mehdi Mahammadli, Sonya C. Faber, et al.
International Journal of Mental Health and Addiction (2023) Vol. 22, Iss. 2, pp. 913-937
Closed Access | Times Cited: 4
Psychedelic-assisted therapy for people with gambling disorder?
Pedro Romero, Andrea Czakó, Wim van den Brink, et al.
Journal of Behavioral Addictions (2024) Vol. 13, Iss. 1, pp. 6-11
Open Access | Times Cited: 1
Considering distinct positive emotions in psychedelic science
Sean P. Goldy, Peter S. Hendricks, Dacher Keltner, et al.
International Review of Psychiatry (2024), pp. 1-12
Closed Access | Times Cited: 1
Restructuring insight: An integrative review of insight in problem-solving, meditation, psychotherapy, delusions and psychedelics
Kadi Tulver, Karl Kristjan Kaup, Ruben Laukkonen, et al.
(2021)
Open Access | Times Cited: 11
Exploring the Unique Therapeutic Potential of Psychedelics to Reduce Chronic Shame Among Sexual and Gender Minority Adults
Nicholas A. Carlisle, Haley Maria Dourron, Sarah MacCarthy, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 4, pp. 210-217
Closed Access | Times Cited: 4
Adapting psychedelic medicine for headache and chronic pain disorders
Emmanuelle A. D. Schindler, Peter S. Hendricks
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 10, pp. 867-882
Closed Access | Times Cited: 2
Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use
David S. Mathai, Daniel E. Roberts, Sandeep M. Nayak, et al.
(2023)
Open Access | Times Cited: 2
Deconstructing Psychedelic Phenomenology: A thematic analysis of discrete phases of the psychedelic experience.
Hugh McGovern, Lura Bajo, Gerard Hassed, et al.
(2024)
Open Access
Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives
Bushra Yasin, Shivani Mehta, George Tewfik, et al.
Exploration of neuroscience (2024) Vol. 3, Iss. 5, pp. 418-433
Open Access
Hemispheric annealing and lateralization under psychedelics (HEALS): A novel hypothesis of psychedelic action in the brain
Adam W. Levin
Journal of Psychopharmacology (2024)
Closed Access
Ayahuasca in the treatment of bipolar disorder with psychotic features–A retrospective case study
Mika Turkia
(2023)
Open Access | Times Cited: 1
A Qualitative Analysis of First-Hand Accounts of Diphenhydramine Misuse Available on YouTube
Haley Maria Dourron, Heith Copes, Agasthya Vedre-Kyanam, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 5, pp. 648-656
Closed Access | Times Cited: 1
Page 1

Scroll to top